Can GDF-15 Predict Bleeding Risk in VTE? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Timothy Hoberstorfer et al., adding:
“Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Growth differentiation factor-15 has been proposed as a marker of bleeding risk, but it did not deliver here.
In patients anticoagulated for acute venous thromboembolism, GDF-15 levels showed no association with clinically relevant bleeding and added nothing to existing bleeding prediction.
The result argues against using this biomarker to guide anticoagulation decisions in VTE.”
Title: Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Cornelia Englisch, Philip Kienzl, Benedikt Weber, Monika Fritzer-Szekeres, Ingrid Pabinger, Cihan Ay
Other articles about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation